PEL Evidence Review · September 15, 2026
Ascend BioLabs alternatives by material
Twelve source-dated comparisons with direct PEL option links and original analytical documents.
BPC-157
Standalone BPC-157 is distinct from Wolverine or another BPC-containing blend.
Compare options and sources →TB-500
A blend total cannot establish the amount of a standalone TB-500 offer.
Compare options and sources →GHK-Cu
The PEL 100 mg option is a different amount; a common material label alone does not establish a match.
Compare options and sources →NAD+
Compare a standalone NAD+ product separately from a multi-product bundle and from NADH or a precursor.
Compare options and sources →Semax
The PEL 5 mg and 10 mg options require separate quantity and report checks.
Compare options and sources →Selank
A bundle description does not establish a standalone Selank price or current availability.
Compare options and sources →MT-2
MT-2 is not MT-1; keep their supplier and laboratory records separate.
Compare options and sources →Wolverine Stack
The captured source did not establish the component quantities. PEL lists TB-500 10 mg plus BPC-157 10 mg.
Compare options and sources →GLOW
A total of 70 mg does not establish component-by-component equivalence. PEL lists GHK-Cu 50 mg, TB-500 10 mg and BPC-157 10 mg.
Compare options and sources →CJC-1295 (no DAC)
PEL’s standalone listing is no DAC. These must not be presented as the same form or an exact substitute.
Compare options and sources →Tesa / TH9507
The PEL Tesa / TH9507 10 mg and 20 mg options need an exact other-supplier label and amount before matching.
Compare options and sources →KLOW
PEL’s KLOW has four listed components. Do not import quantities from GLOW or another supplier’s similarly named blend.
Compare options and sources →How these comparisons are sourced
PEL options and displayed report links come from PEL’s catalog. Ascend observations come from its original homepage captured September 11, 2026. The current offer, price and product-specific original documents remain unverified unless explicitly identified. We do not turn a similar label into an equivalence claim.